{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "esgPopulated": false, "market": "dr_market", "longName": "Alligator Bioscience AB (publ)", "marketState": "REGULAR", "regularMarketPrice": 0.0448, "messageBoardId": "finmb_3206363", "exchange": "FRA", "shortName": "ALLIGATOR BIOSC. AB O.N.", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Berlin", "regularMarketChangePercent": 30.994143, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 0.011, "fiftyTwoWeekLowChangePercent": 0.3254438, "fiftyTwoWeekRange": "0.0338 - 0.22", "fiftyTwoWeekHighChange": -0.1752, "fiftyTwoWeekHighChangePercent": -0.79636365, "fiftyTwoWeekLow": 0.0338, "fiftyTwoWeekHigh": 0.22, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.05, "firstTradeDateMilliseconds": 1480057200000, "priceHint": 4, "regularMarketChange": 0.010599997, "regularMarketTime": 1683880220, "regularMarketDayHigh": 0.0448, "regularMarketDayRange": "0.0448 - 0.0448", "regularMarketDayLow": 0.0448, "regularMarketVolume": 205, "regularMarketPreviousClose": 0.0342, "bid": 0.0412, "ask": 0.0609, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.0448, "averageDailyVolume3Month": 217, "averageDailyVolume10Day": 20, "sharesOutstanding": 363964992, "bookValue": 0.787, "fiftyDayAverage": 0.07994288, "fiftyDayAverageChange": -0.035142884, "fiftyDayAverageChangePercent": -0.4395999, "twoHundredDayAverage": 0.13674071, "twoHundredDayAverageChange": -0.091940716, "twoHundredDayAverageChangePercent": -0.67237264, "marketCap": 16305631, "priceToBook": 0.05692503, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "7AL.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Medicon Village", "address2": "ScheelevAegen 2", "city": "Lund", "zip": "223 81", "country": "Sweden", "phone": "46 4 65 40 82 00", "website": "https://www.alligatorbioscience.se", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Sweden. The company's product portfolio includes Mitazalimab, an agonistic antibody that targets CD40, which is in phase 2 clinical trail for the treatment solid metastatic tumors, initially pancreatic cancer; and ATOR-4066, a bispecific antibody tumor-specific immune effect, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage. It also offers ATOR-1017, a 4-1BB for solid metastatic tumors which is in Phase 1 clinical trial; and ALG.APV-527, which is in phase 2 clinical trail drug that target tumor-associated antigen 4-1BB and 5T4. In addition, the company develops products using its technology platforms, including ALLIGATOR-GOLD and ALLIGATOR-FAB, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and RUBY, a bispecific antibody format. Further, it has collaboration and out-licensing agreements with Aptevo Therapeutics, Inc.; Orion Corporation.; MacroGenics, Inc.; Biotheus; and Abclon. The company was incorporated in 2000 and is headquartered in Lund, Sweden.", "fullTimeEmployees": 58, "companyOfficers": [{"maxAge": 1, "name": "Mr. S\u00f8ren  Bregenholt Ph.D.", "age": 51, "title": "Chief Exec. Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marie  Svensson", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Malin  Carlsson", "age": 54, "title": "Head of R&D, Exec. VP & COO", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Laura  von Schantz", "age": 40, "title": "Chief Technology Officer", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter  Ellmark Ph.D.", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Julie  Silber", "title": "Director of Communications & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sumeet  Ambarkhane M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}